Fri Sep 20 13:53:00 UTC 2024: ## Geographic Atrophy Market Booms, Driven by Aging Population and New Treatments

**Pune, India – September 20, 2024** – The global Geographic Atrophy (GA) market is experiencing rapid growth, with projections indicating a value of USD 50.0 billion by 2032, according to a new report from SNS Insider. This surge is attributed to the rising prevalence of age-related macular degeneration (AMD), a leading cause of vision loss in the elderly.

The report highlights the increasing demand for innovative GA treatment solutions, particularly among the growing geriatric population. As life expectancy increases, the number of individuals susceptible to GA is also rising. This trend is further fueled by heightened awareness of the condition and the development of sophisticated diagnostic tools like Optical Coherence Tomography Angiography (OCT-A).

“The GA market is experiencing a period of significant growth,” says a spokesperson from SNS Insider. “The pipeline for GA therapeutics is expanding with ongoing clinical trials and FDA approvals of new drugs specifically targeting GA. This, coupled with the increasing prevalence of the condition, is driving market expansion.”

The report identifies key players like Iveric Bio, Apellis Pharmaceuticals, and Galderma Laboratories as driving forces in the market. These companies are actively developing innovative treatments and advancing diagnostic capabilities.

While North America currently dominates the market due to robust healthcare infrastructure and a large number of research institutions, the Asia-Pacific region is poised for significant growth in the coming years. This is attributed to the region’s rapidly aging population and increasing healthcare spending.

The report also examines the market segmentation by age group, diagnostic methods, and therapeutic agents, highlighting the significant role of Phase III clinical trials in driving innovation.

The report concludes that the Geographic Atrophy market is well-positioned for continued growth, driven by a confluence of factors including an aging global population, technological advancements, and a robust pipeline of new treatments.

**About SNS Insider:**

SNS Insider is a leading market research and consulting agency, providing clients with valuable insights into dynamic market trends. They employ a range of research methodologies to deliver accurate and up-to-date market data.

Read More